fda approved weight loss glp-1 The has the first pill for loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular GLP-1 Injections for Medical Weight

Future research must prioritize improving the interpretability of AI models to facilitate their broader application in Chinese medicine research and ensure their effectiveness and safety in clinical decision-making

or rapid heartbeat. Optic nerve damage in people with certain hereditary eye disorders (e.g., Lebers optic neuropathy). Worsening of gout or high uric acid levels. Elevated homocysteine levels, which may increase cardiovascular risk in susceptible individuals.Who should not use Lipo-C: Do not use Lipo-C if you are allergic to methionine, inositol, choline, any B-vitamin, or any other component of the formulation. Do not use Lipo-C if you have severe liver disease, chronic kidney disease, active peptic ulcer disease, or a history of Lebers optic neuropathy. Do not use Lipo-C if you are pregnant or breastfeeding.Before starting Lipo-C, tell your healthcare provider if you have any other medical conditions, including if you: Have or have had problems with your liver or kidneys. Have cardiovascular disease, high cholesterol, or elevated homocysteine levels. Have gout, hyperuricemia, or a history of kidney stones. Have pernicious anemia or folate deficiency. Are taking prescription medications, over-the-counter medicines, vitamins, or herbal supplements.Serious side effects can occur with Lipo-C

E.MutschlerE

Catalano PM, Drago NM, Amini SB